Textbook of Pediatric Rheumatology
1. Introduction - p. 377 2. Demographics and Epidemiology - p. 377 3. Etiology and Pathogenesis - p. 377 4. Diagnosis and Classification of Juvenile Systemic Sclerosis - p. 380 5. Clinical Features - p. 383 6. Patient Reported Outcomes - p. 392 7. Systemic Sclerosis Treatment - p. 394 8. Raynaud Phenomenon - p. 396 9. Digital Ulcers - p. 396 10. The Future of Treatment in Pediatric Systemic Sclerosis - p. 400 11. Prognosis - p. 400 12. 28. Localized Scleroderma and Eosinophilic Fasciitis - p. 402 13. 29. Sjögren Syndrome and Immunoglobulin-G4 Disease - p. 417 14. 30. Raynaud Phenomenon and Vasomotor Syndromes - p. 427 15. Section IV. Vasculitis - p. 437.e3 16. 31. Inflammatory Central Nervous System Disorders - p. 439 17. 32. Vasculitis and Its Classification - p. 451 18. 33. Immune Complex Small-Vessel Vasculitis: IgA Vasculitis (Henoch–Schönlein) and Hypersensitivity Vasculitis - p. 456 19. 34. Polyarteritis Nodosa - p. 467 20. 35. Kawasaki Disease - p. 473 21. 36. Antineutrophil Cytoplasmic Antibody Associated Vasculitis - p. 484 22. 37. Takayasu Arteritis and Other Vasculitides - p. 498 23. Takayasu Arteritis - p. 498 24. Cogan Syndrome - p. 506 25. Immune Complex Small-Vessel Vasculitis - p. 507 26. Vasculitis Associated With Systemic Disease - p. 509 27. Vasculitis Associated With Probable Etiology - p. 510 28. Other Vasculitides, Vasculopathies - p. 511 29. Mimics of Vasculitis - p. 515 30. 38. Behçet Disease - p. 518 31. Section V. Immune System Dysfunction: Autoinflammation and Immunodeficiency - p. 523.e2 32. 39. Periodic Fever Syndromes and Other Inherited Autoinflammatory Diseases - p. 525 33. 40. Autoinflammatory Bone Diseases - p. 544 34. 41. Pediatric Sarcoidosis - p. 559 35. 42. Macrophage Activation Syndrome - p. 567 36. 43. Primary Immunodeficiencies and Rheumatic Diseases - p. 575 37. Section VI. Infection Related Rheumatic Disorders - p. 585.e4 38. 44. Infectious Arthritis and Osteomyelitis - p. 587 39. 45. Lyme Disease - p. 602 40. 46. Reactive Arthritis - p. 613 41. Section VII. Rheumatic Manifestations of Non-Rheumatic Disorders - p. 630.e5 42. 47. Skeletal Malignancies and Related Disorders - p. 631 43. 48. The Impact of Rheumatic Diseases and Their Treatment on Bone Strength Development in Childhood - p. 644 44. 49. Skeletal Dysplasias - p. 657 45. 50. Noninflammatory Musculoskeletal Pain - p. 665 46. 51. Musculoskeletal Manifestations of Inflammatory Bowel Disease - p. 684 47. 52. Musculoskeletal Manifestations of Systemic Disease - p. 691 48. 53. Pain Amplification Syndromes - p. 702 49. 54. Primary Disorders of Connective Tissue - p. 714 50. Index - p. 725
Textbook of Pediatric Rheumatology
1. Introduction - p. 377 2. Demographics and Epidemiology - p. 377 3. Etiology and Pathogenesis - p. 377 4. Diagnosis and Classification of Juvenile Systemic Sclerosis - p. 380 5. Clinical Features - p. 383 6. Patient Reported Outcomes - p. 392 7. Systemic Sclerosis Treatment - p. 394 8. Raynaud Phenomenon - p. 396 9. Digital Ulcers - p. 396 10. The Future of Treatment in Pediatric Systemic Sclerosis - p. 400 11. Prognosis - p. 400 12. 28. Localized Scleroderma and Eosinophilic Fasciitis - p. 402 13. 29. Sjögren Syndrome and Immunoglobulin-G4 Disease - p. 417 14. 30. Raynaud Phenomenon and Vasomotor Syndromes - p. 427 15. Section IV. Vasculitis - p. 437.e3 16. 31. Inflammatory Central Nervous System Disorders - p. 439 17. 32. Vasculitis and Its Classification - p. 451 18. 33. Immune Complex Small-Vessel Vasculitis: IgA Vasculitis (Henoch–Schönlein) and Hypersensitivity Vasculitis - p. 456 19. 34. Polyarteritis Nodosa - p. 467 20. 35. Kawasaki Disease - p. 473 21. 36. Antineutrophil Cytoplasmic Antibody Associated Vasculitis - p. 484 22. 37. Takayasu Arteritis and Other Vasculitides - p. 498 23. Takayasu Arteritis - p. 498 24. Cogan Syndrome - p. 506 25. Immune Complex Small-Vessel Vasculitis - p. 507 26. Vasculitis Associated With Systemic Disease - p. 509 27. Vasculitis Associated With Probable Etiology - p. 510 28. Other Vasculitides, Vasculopathies - p. 511 29. Mimics of Vasculitis - p. 515 30. 38. Behçet Disease - p. 518 31. Section V. Immune System Dysfunction: Autoinflammation and Immunodeficiency - p. 523.e2 32. 39. Periodic Fever Syndromes and Other Inherited Autoinflammatory Diseases - p. 525 33. 40. Autoinflammatory Bone Diseases - p. 544 34. 41. Pediatric Sarcoidosis - p. 559 35. 42. Macrophage Activation Syndrome - p. 567 36. 43. Primary Immunodeficiencies and Rheumatic Diseases - p. 575 37. Section VI. Infection Related Rheumatic Disorders - p. 585.e4 38. 44. Infectious Arthritis and Osteomyelitis - p. 587 39. 45. Lyme Disease - p. 602 40. 46. Reactive Arthritis - p. 613 41. Section VII. Rheumatic Manifestations of Non-Rheumatic Disorders - p. 630.e5 42. 47. Skeletal Malignancies and Related Disorders - p. 631 43. 48. The Impact of Rheumatic Diseases and Their Treatment on Bone Strength Development in Childhood - p. 644 44. 49. Skeletal Dysplasias - p. 657 45. 50. Noninflammatory Musculoskeletal Pain - p. 665 46. 51. Musculoskeletal Manifestations of Inflammatory Bowel Disease - p. 684 47. 52. Musculoskeletal Manifestations of Systemic Disease - p. 691 48. 53. Pain Amplification Syndromes - p. 702 49. 54. Primary Disorders of Connective Tissue - p. 714 50. Index - p. 725
